World News
Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — CHICAGO — An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found.
Among 559 participants in ACHIEVE…



